Paavo Raittinen
Contingent Worker
Contingent Worker
T302 Dept. Mathematics and Systems Analysis
Full researcher profile
https://research.aalto.fi/...
Yhteystiedot
Sähköposti
[email protected]
Julkaisut
On statistical analysis and machine learning in prostate cancer research
Paavo Raittinen
2022
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy
Aino Siltari, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Otto Ettala, Peter Boström, Heikki Seikkula, Andres Kotsar, Teuvo Tammela, Mika Helminen, Paavo V. Raittinen, Terho Lehtimäki, Mikkel Fode, Peter Østergren, Michael Borre, Antti Rannikko, Timo Marttila, Arto Salonen, Hanna Ronkainen, Sven Löffeler, Teemu J. Murtola
2022
BMJ Open
Outcomes of Screening for Prostate Cancer among Men Who Use Statins
Arla Vettenranta, Teemu J. Murtola, Jani Raitanen, Paavo Raittinen, Kirsi Talala, Kimmo Taari, Ulf Håkan Stenman, Teuvo L.J. Tammela, Anssi Auvinen
2022
JAMA Oncology
Nationwide infection control strategy lowered seasonal respiratory infection rate: occupational health care perspective during the COVID-19 epidemic in Finland
Miika Arvonen, Paavo Raittinen, Oskar Niemenoja, Pauliina Ilmonen, Sari Riihijärvi, Simo Särkkä, Lauri Viitasaari
2021
Infectious Diseases
Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study
A. I. Peltomaa, P. Raittinen, K. Talala, K. Taari, T. L.J. Tammela, A. Auvinen, T. J. Murtola
2021
PROSTATE CANCER AND PROSTATIC DISEASES
Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial
Paavo Raittinen, Heimo Syvälä, Teuvo L.J. Tammela, Merja Häkkinen, Pauliina Ilmonen, Seppo Auriola, Teemu J. Murtola
2021
Ebiomedicine
Single Cell Trapping by Superhydrophobic/Superhydrophilic Microarrays
Paavo Raittinen, Pinja Elomaa, Päivi Saavalainen, Ville Jokinen
2021
Advanced Materials Interfaces
Antidiabetic drugs and prostate cancer prognosis in a Finnish population-based cohort
Ville J Vihervuori, Kirsi Talala, Kimmo Taari, Jorma Lahtela, Teuvo Tammela, Anssi Auvinen, Paavo V. H. Raittinen, Teemu J. Murtola
2021
CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION
Serum thymidine kinase 1 levels predict prostate cancer-specific survival
Teemu J. Murtola, Paavo Raittinen, Teuvo Tammela
2020
CANCER RESEARCH
Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer
Paavo Raittinen, Kati Niemistö, Erika Pennanen, Heimo Syvälä, Seppo Auriola, Jarno Riikonen, Terho Lehtimäki, Pauliina Ilmonen, Teemu Murtola
2020
Scientific Reports